SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations
Meggendorfer, M, Bacher, U, Alpermann, T, Haferlach, C, Kern, W, Gambacorti-Passerini, C, Haferlach, T, Schnittger, S
Published in Leukemia (01.09.2013)
Published in Leukemia (01.09.2013)
Get full text
Journal Article
Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma
Ceccon, M, Mologni, L, Giudici, G, Piazza, R, Pirola, A, Fontana, D, Gambacorti-Passerini, C
Published in Molecular cancer research (01.04.2015)
Published in Molecular cancer research (01.04.2015)
Get full text
Journal Article
Direct determination of chronic myeloid leukemia prevalence in Lombardy—Italy: Global implications
Polverelli, N., Anghilieri, M., Elena, C., Intermesoli, T., Pungolino, E., D’Adda, M., Iurlo, A., Maffioli, M., Lunghi, F., Bertolli, V., Orofino, N., Sissa, C., Fiamenghi, C., Gardellini, A., Ubezio, M., Carraro, M. C., Corradini, P., Giglio, F., Pasquini, M. C., Palazzolo, R., Calori, R., Ercolanoni, M., Gambacorti‐Passerini, C.
Published in Hematological oncology (01.09.2024)
Published in Hematological oncology (01.09.2024)
Get full text
Journal Article
Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase
CORTES, J, KIM, D.-W, HOCHHAUS, A, KHOURY, H. J, BROMMENDORF, T. H, MICHALLET, M, REGE-CAMBRIN, G, GAMBACORTI-PASSERINI, C, RADICH, J. P, ERNST, T, ZHU, C, VAN TORNOUT, J. M. A, RAFFOUX, E, TALPAZ, M, MARTINELLI, G, RITCHIE, E, ROY, L, COUTRE, S, CORM, S, HAMERSCHLAK, N, TANG, J.-L
Published in Leukemia (01.12.2008)
Published in Leukemia (01.12.2008)
Get full text
Journal Article
A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias
Cortes, J.E, Kim, D.-W, Pinilla-Ibarz, J, le Coutre, P, Paquette, R, Chuah, C, Nicolini, F.E, Apperley, J.F, Khoury, H.J, Talpaz, M, DiPersio, J, DeAngelo, D.J, Abruzzese, E, Rea, D, Baccarani, M, Müller, M.C, Gambacorti-Passerini, C, Wong, S, Lustgarten, S, Rivera, V.M, Clackson, T, Turner, C.D, Haluska, F.G, Guilhot, F, Deininger, M.W, Hochhaus, A, Hughes, T, Goldman, J.M, Shah, N.P, Kantarjian, H
Published in The New England journal of medicine (07.11.2013)
Published in The New England journal of medicine (07.11.2013)
Get full text
Journal Article
Idiopathic erythrocytosis: a germline disease?
Elli, E. M., Mauri, M., D’Aliberti, D., Crespiatico, I., Fontana, D., Redaelli, S., Pelucchi, S., Spinelli, S., Manghisi, B., Cavalca, F., Aroldi, A., Ripamonti, A., Ferrari, S., Palamini, S., Mottadelli, F., Massimino, L., Ramazzotti, D., Cazzaniga, G., Piperno, A., Gambacorti-Passerini, C., Piazza, R.
Published in Clinical and experimental medicine (20.01.2024)
Published in Clinical and experimental medicine (20.01.2024)
Get full text
Journal Article
Management and outcome of 11 pregnancies in women with polycythemia vera
Elli, E.M., Diral, E., Gambacorti-Passerini, C., Calori, R., Carmosino, I., Breccia, M., Latagliata, R., Di Veroli, A.
Published in Leukemia research (01.06.2019)
Published in Leukemia research (01.06.2019)
Get full text
Journal Article
Efficacy and safety of bosutinib vs imatinib in Indian and non-Indian patients with newly diagnosed chronic phase chronic myeloid leukemia: Subgroup analysis from the BELA trial
Malhotra, H., Maru, A., Khattry, N., Ramanan, M.V., Leip, E., Crescenzo, R.J., Gambacorti-Passerini, C., Cortes, J.E.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
P717: BOSUTINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA: GASTROINTESTINAL, LIVER, EFFUSION AND RENAL SAFETY CHARACTERIZATION IN THE BFORE TRIAL
Cortes, J. E., Milojkovic, D., Gambacorti‐Passerini, C., García‐Gutiérrez, V., Mauro, M. J., Leip, E., Purcell, S., Viqueira, A., Brümmendorf, T. H.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
P719: EFFICACY AND SAFETY OF BOSUTINIB IN LATER‐LINE PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A SUB‐ANALYSIS FROM THE PHASE 4 BYOND TRIAL
Gambacorti‐Passerini, C., Brümmendorf, T. H., Ernst, T., Leip, E., Purcell, S., Viqueira, A., Giles, F. J., Rosti, G., Hochhaus, A.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
S157: BCR::ABL1 DIGITAL PCR IDENTIFIES CHRONIC PHASE CML PATIENTS SUITABLE FOR AN EARLY TKI DISCONTINUATION ATTEMPT: A PATIENT‐LEVEL META‐ANALYSIS
Kockerols, C., Dulucq, S., Bernardi, S., Farina, M., Civettini, I., Colafigli, G., Mori, S., Valk, P., Mahon, F.‐X., Gambacorti‐Passerini, C., Nicolini, F.‐E., Breccia, M., Russo, D., Westerweel, P. E.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
P520: PHASE 1/2 STUDY OF SEL24/MEN1703, A FIRST‐IN‐CLASS DUAL PIM/FLT3 KINASE INHIBITOR, IN PATIENTS WITH IDH1/2‐MUTATED ACUTE MYELOID LEUKEMIA: THE DIAMOND‐01 TRIAL
Martinelli, G., Santoro, A., Gambacorti‐Passerini, C., Vives Polo, S., Solomon, S. R., Mukherjee, S., Lech‐Maranda, E., Yair Levy, M., Wierzbowska, A., Calbacho‐Robles, M., Marconi, G., Benedetta Giannini, M., Cano, I., Torres Miñana, L., Acuña‐Cruz, E., Angelosanto, N., Galleu, A., Baldini, S., Blotta, S., Ravandi, F., Montesinos, P.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase blast crisis CML patients
MAREGA, M, PIAZZA, R. G, PIROLA, A, REDAELLI, S, MOGAVERO, A, LACOBUCCI, I, MENEGHETTI, I, PARMA, M, POGLIANI, E. M, GAMBACORTI-PASSERINI, C
Published in Leukemia (01.08.2010)
Published in Leukemia (01.08.2010)
Get full text
Journal Article
Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells
FALANGA, A, CONSONNI, R, MARCHETTI, M, LOCATELLI, G, GARATTINI, E, GAMBACORTI PASSERINI, C, GORDON, S. G, BARBUI, T
Published in Blood (01.07.1998)
Published in Blood (01.07.1998)
Get full text
Journal Article
Synergistic activity of the Src Abl inhibitor bosutinib in combination with imatinib
REDAELLI, S, BOSCHELLI, F, PERINI, P, PIROLA, A, VILTADI, M, GAMBACORTI-PASSERINI, C
Published in Leukemia (01.06.2010)
Published in Leukemia (01.06.2010)
Get full text
Journal Article
Roots of clinical resistance to STI-571 cancer therapy
Barthe, C, Cony-Makhoul, P, Melo, J V, Mahon, J R
Published in Science (American Association for the Advancement of Science) (21.09.2001)
Published in Science (American Association for the Advancement of Science) (21.09.2001)
Get full text
Journal Article
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency
Ceccon, Monica, Merlo, Maria Elena Boggio, Mologni, Luca, Poggio, Teresa, Varesio, Lydia M, Menotti, Matteo, Bombelli, Silvia, Rigolio, Roberta, Manazza, Andrea D, Di Giacomo, Filomena, Ambrogio, Chiara, Giudici, Giovanni, Casati, Cesare, Mastini, Cristina, Compagno, Mara, Turner, Suzanne D, Gambacorti-Passerini, Carlo, Chiarle, Roberto, Voena, Claudia
Published in Oncogene (21.07.2016)
Published in Oncogene (21.07.2016)
Get full text
Journal Article